Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹75.90Admitted-Finance NA | NA | NA | 121004 | ₹75.90 | L1 | Admitted-Finance |
| 2 | L2₹95+₹19.10 (25.2%)Admitted-Finance | ₹95+₹19.10 (25.2%) | L2 | Admitted-Finance |
| 3 | L3₹261.50+₹185.60 (244.5%)Admitted-Finance | ₹261.50+₹185.60 (244.5%) | L3 | Admitted-Finance |
| Sl No | Description | Qty | Unit | Fresenius Kabi Oncology Limited L2 | ADMAC LIFESCIENCES L3 | Beta Drugs Limited L1 |
|---|---|---|---|---|---|---|
| 1.00 | AZATHIOPRINE TAB IP 50 mg | 1,06,631 | 1 No | - | - | - |
| 2.00 | CYCLOPHOSPHAMIDE TAB IP 50 mg | 34,825 | 1 No | - | - | - |
| 3.00 | DACARBAZINE INJ IP/USP 200 mg | 1,250 | Vial | - | - | - |
| 4.00 | DACTINOMYCIN INJ 0.5 mg/3 ml | 70 | Vial | - | - | - |
| 5.00 | DAUNORUBICIN INJ IP 20 mg | 642 | Vial | - | 230 ₹241.5 Lowest | - |
| 6.00 | DEXAMETHASONE TAB IP 8 mg | 1,27,416 | 1 No | - | - | - |
| 7.00 | DEXAMETHASONE TAB IP 4 mg | 1,43,651 | 1 No | - | - | - |
| 8.00 | ENZALUTAMIDE CAP 80 mg | 8,450 | 1 No | - | - | - |
| 9.00 | EXEMESTANE TAB IP 25 mg | 7,945 | 1 No | - | - | - |
| 10.00 | FLUDARABINE PHOSPHATE INJ IP/
USP 50 mg | 1 | Vial | - | - | - |
Tender Value
Refer Docs
EMD Value
₹50,000
Closing Date
18 May 2026, 5:00 pmClosed
Managing Director
KMSCL, THYCAUD
Re-tender for the procurement Anti cancer drugs for the year 2026-27
2026_KMSCL_849143_1
KMSCL/ED/ACD/RT/2026/013
Open Tender
Medicines
Item Wise
365 days
Thiruvananthapuram
Please refer tender document
22 documents required · 22 mandatory
₹29,500
Yes
₹50,000
Yes
11 Jun 2026
30 Apr 2026
20 May 2026
30 Apr 2026
18 May 2026
30 Apr 2026
30 Apr 2026 - 18 May 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1 | AZATHIOPRINE TAB IP 50 mg | 1,06,631 | 1 No | 5 | ₹5,33,155 |
| 2 | CYCLOPHOSPHAMIDE TAB IP 50 mg | 34,825 | 1 No | 5 | ₹1,74,125 |
| 3 | DACARBAZINE INJ IP/USP 200 mg | 1,250 | Vial | 5 | ₹6,250 |
| 4 | DACTINOMYCIN INJ 0.5 mg/3 ml | 70 | Vial | 5 | ₹350 |
| 5 | DAUNORUBICIN INJ IP 20 mg | 642 | Vial | 5 | ₹3,210 |
| 6 | DEXAMETHASONE TAB IP 8 mg | 1,27,416 | 1 No | 5 | ₹6,37,080 |
| 7 | DEXAMETHASONE TAB IP 4 mg | 1,43,651 | 1 No | 5 | ₹7,18,255 |
| 8 | ENZALUTAMIDE CAP 80 mg | 8,450 | 1 No | 5 | ₹42,250 |
| 9 | EXEMESTANE TAB IP 25 mg | 7,945 | 1 No | 5 | ₹39,725 |
| 10 | FLUDARABINE PHOSPHATE INJ IP/
USP 50 mg | 1 | Vial | 5 | ₹5 |
stage.html
html • 0.03 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.04 MB
Tendernotice_1.pdf
PDF • 0.54 MB
BOQ_1434897.xls
BOQ • 0.34 MB
ACD.pdf
Tender Documents • 1.80 MB
TimeExtensionnotice.pdf
PDF • 0.37 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .